NCT00601939 Effectiveness of Empowerment Group Sessions for Treating Suicidal African American Women in Abusive Relationships
| NCT ID | NCT00601939 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Emory University |
| Condition | Battered Women |
| Study Type | INTERVENTIONAL |
| Enrollment | 397 participants |
| Start Date | 2008-03 |
| Primary Completion | 2028-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 397 participants in total. It began in 2008-03 with a primary completion date of 2028-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will evaluate the effectiveness of culturally competent psychoeducational empowerment sessions in treating suicidal African-American women who are in abusive relationships.
Eligibility Criteria
Inclusion Criteria: * Identifies as an African-American female * Abusive relationship within the 12 months prior to study entry * Suicide attempt within the 12 months prior to study entry * Seeks services at Grady Health System Exclusion Criteria: * Score of less than 22 on Mini Mental Status Exam (MMSE) * Score of less than 18 on Rapid Estimate of Adult Literacy in Medicine (REALM) * Acutely psychotic
Contact & Investigator
Nadine J. Kaslow, PhD
PRINCIPAL INVESTIGATOR
Emory University
Frequently Asked Questions
Who can join the NCT00601939 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 64 Years, studying Battered Women. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT00601939 currently recruiting?
Yes, NCT00601939 is actively recruiting participants. Contact the research team at nkaslow@emory.edu for enrollment information.
Where is the NCT00601939 trial being conducted?
This trial is being conducted at Atlanta, United States.
Who is sponsoring the NCT00601939 clinical trial?
NCT00601939 is sponsored by Emory University. The principal investigator is Nadine J. Kaslow, PhD at Emory University. The trial plans to enroll 397 participants.